Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LR20062
- Development stage
- Phase 2
- Lead developer
- LG Chem
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
LR20062 is an investigational **acellular pertussis-based DTaP-HepB-IPV-Hib hexavalent pediatric vaccine** developed by LG Chem. It is a fixed-dose 6-in-1 immunization product intended to induce protective immunity against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and *Haemophilus influenzae* type b disease. LG Chem has evaluated LR20062 as an intramuscular primary series at 2, 4, and 6 months of age in healthy infants in a randomized, double-blind, active-controlled Phase 2 trial. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06618196))
02
Targets
HBsAg-specific BCR (HBsAg-specific B-cell receptor)Diphtheria toxin antigen-specific B-cell receptor / antibody repertoireInactivated poliovirus antigen-specific B-cell receptor / antibody repertoireHaemophilus influenzae type b capsular antigen-specific B-cell receptor / antibody repertoire
Beyond the preview
Go deeper on LR20062.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LR20062.